1. Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, Harbin, 150001, China 2. The Fourth Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, 150001, China 3. Department of Abdominal Ultrasound, First Hospital of Harbin Medical University, Harbin, 150001, China 4. Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA 5. Department of Endocrinology, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150001, China #These authors contributed equally to this work and should be considered co-first authors
✉ Corresponding authors: Jianqun Ma, Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, 150, Haping Road, Harbin, 150001, China. Tel: 0451-86298631; E-mail: jianqunmahydcom and Shidong Xu, Department of Thoracic Surgery, Harbin Medical University Cancer Hospital, 150, Haping Road, Harbin, 150001, China. Tel: 0451-85718182; E-mail: shidongxuhydcomMore
Citation:
Wang F, Liu W, Ning J, Wang J, Lang Y, Jin X, Zhu K, Wang X, Li X, Yang F, Ma J, Xu S. Simvastatin Suppresses Proliferation and Migration in Non-small Cell Lung Cancer via Pyroptosis. Int J Biol Sci 2018; 14(4):406-417. doi:10.7150/ijbs.23542. https://www.ijbs.com/v14p0406.htm
Pyroptosis is a form of caspase-1-dependent programmed cell death with anti-tumor properties, but the underlying molecular mechanisms are not fully understood. The results of our study showed that the antihyperlipidemic drug simvastatin induced pyroptosis in non-small cell lung cancer (NSCLC) cell lines and a xenograft mouse model. Inhibition of pyroptosis attenuated the effects of simvastatin on tumor cell viability and migration. These data suggest that simvastatin may induce pyroptosis, thereby potentially serving as a novel therapeutic agent for NSCLC.
Keywords: Simvastatin, NSCLC, pyroptosis, caspase-1, cancer therapy
Citation styles
APA
Wang, F., Liu, W., Ning, J., Wang, J., Lang, Y., Jin, X., Zhu, K., Wang, X., Li, X., Yang, F., Ma, J., Xu, S. (2018). Simvastatin Suppresses Proliferation and Migration in Non-small Cell Lung Cancer via Pyroptosis. International Journal of Biological Sciences, 14(4), 406-417. https://doi.org/10.7150/ijbs.23542.
ACS
Wang, F.; Liu, W.; Ning, J.; Wang, J.; Lang, Y.; Jin, X.; Zhu, K.; Wang, X.; Li, X.; Yang, F.; Ma, J.; Xu, S. Simvastatin Suppresses Proliferation and Migration in Non-small Cell Lung Cancer via Pyroptosis. Int. J. Biol. Sci. 2018, 14 (4), 406-417. DOI: 10.7150/ijbs.23542.
NLM
Wang F, Liu W, Ning J, Wang J, Lang Y, Jin X, Zhu K, Wang X, Li X, Yang F, Ma J, Xu S. Simvastatin Suppresses Proliferation and Migration in Non-small Cell Lung Cancer via Pyroptosis. Int J Biol Sci 2018; 14(4):406-417. doi:10.7150/ijbs.23542. https://www.ijbs.com/v14p0406.htm
CSE
Wang F, Liu W, Ning J, Wang J, Lang Y, Jin X, Zhu K, Wang X, Li X, Yang F, Ma J, Xu S. 2018. Simvastatin Suppresses Proliferation and Migration in Non-small Cell Lung Cancer via Pyroptosis. Int J Biol Sci. 14(4):406-417.
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.